한국인 류마티스관절염과 골관절염 환자의 위장관 위험인자와 비스테로이드항염제 사용 비교open accessGastrointestinal Risk Factors and Non-steroidal Anti-inflammatory Drugs Use in Rheumatoid Arthritis and Osteoarthritis Patients in Korea
- Other Titles
- Gastrointestinal Risk Factors and Non-steroidal Anti-inflammatory Drugs Use in Rheumatoid Arthritis and Osteoarthritis Patients in Korea
- Authors
- 이은영; 홍승재; 박용범; 박경수; 최찬범; 이창근; 송란; 이윤종; 서창희; 김현아; 민준기; 윤종현; 박원; 정원태; 김근태; 최정윤; 강성욱; 박용욱; 류완희; 이상헌
- Issue Date
- Feb-2016
- Publisher
- 대한류마티스학회
- Keywords
- Rheumatoid arthritis; Osteoarthritis; Gastrointestinal risk factors; Non-steroidal anti-inflammatory agents
- Citation
- 대한류마티스학회지, v.23, no.1, pp.47 - 54
- Indexed
- KCI
- Journal Title
- 대한류마티스학회지
- Volume
- 23
- Number
- 1
- Start Page
- 47
- End Page
- 54
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/5123
- DOI
- 10.4078/jrd.2016.23.1.47
- ISSN
- 2093-940X
- Abstract
- Objective.
The aim of this study was to examine and compare the gastrointestinal (GI) risk factors and treatment patterns of rheumatoid arthritis (RA) and osteoarthritis (OA) patients in Korea.
Methods.
This was a cross-sectional, observational study on RA and OA patients taking non-steroidal anti-inflammatory drugs (NSAIDs) for at least 1 month. A total of 1,896 patients (981 RA patients, 915 OA patients) were recruited from 20 university hospitals. Data were collected through medical records and patient surveys. GI risk factors included age, prolonged (over 3 months) or high-dose use of NSAIDs, alcohol drinking, smoking, use of aspirin, anticoagulants or glucocorticoids, comorbidities, and history of Helicobacter pylori infection or other GI complications. Treatment patterns were classified according to groups using, selective cyclooxygenase (COX)-2 inhibitors± gastro-protective agents, non-selective COX-2 inhibitors+proton pump inhibitor, or non-selective COX-2 inhibitors± other gastro-protective agents.
Results.
GI risk factors were highly present in both RA and OA patients. The proportion of prolonged use of NSAIDs, smoking, and glucocorticoid use were higher in RA patients (p<0.001). The proportion of comorbidities and use of aspirin were higher in OA patients (p<0.001). The remaining GI risk factors were present in similar proportions in both groups. Use of selective COX-2 inhibitors or gastro-protective agents was higher in RA patients.
Conclusion.
Prolonged use of NSAIDs and concomitant glucocorticoid use were higher in RA patients, while comorbidities and concomitant aspirin use were predominant in OA patients. These results will provide insights for use in development of future guidelines for proper selection of NSAIDs and effective prevention of GI complications in arthritis patients. (J Rheum Dis 2016;23:47-54)
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.